Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on lewis acid catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112794794A reveals a high-yield one-pot synthesis for terphenyl macrocycles. Discover cost-effective supply chain solutions for advanced separation materials.
Discover a novel preparation method for Granisetron intermediate 3α-homotropylamine featuring mild conditions, high stereoselectivity, and cost-effective purification suitable for industrial scale-up.
Patent CN113896703A reveals a high-yield green synthesis of daidzein using BF3 and P2O5, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102199130A details a robust zinc-catalyzed route for chiral oxazoline, offering cost-effective solutions for reliable pharmaceutical intermediate suppliers.
Novel Lewis acid catalyzed route for benzo[e]indole intermediates. Reduces steps and enhances supply chain reliability for pharmaceutical manufacturing.
Discover the novel preparation of 2,2,6,6-tetraethyl-3,5-heptanedione using a catalytic Grignard approach. High purity >99% for NMR reagents and OLED applications.
Patent CN112645982A details a scalable synthesis of Remdesivir intermediate INT using Lewis acid catalysis and perfluorinated solvent extraction for superior purity and yield.
Patent CN109776506B details a novel 10-step synthesis of chiral (-)-cephalotaxine from furan. Discover cost-effective manufacturing and supply chain advantages.
Novel synthesis route for HCV intermediate reduces cost and improves purity for pharmaceutical supply chains. Efficient scalable production of high-purity antiviral drug intermediates ensures reliable global supply continuity.
Novel Lewis acid catalyzed reductive amination route offers >99% purity and scalable production for pharmaceutical intermediates.
Patent CN115724783A reveals a novel furfural-based route for asymmetric cyanine dyes, offering superior regioselectivity and cost reduction in biomedical material manufacturing.
Discover the efficient TiCl4-catalyzed synthesis of naphthofuran derivatives from patent CN109574967B. A cost-effective, mild route for high-purity pharmaceutical intermediates.
Patent CN101225027A reveals a solvent-free zinc-catalyzed route for stilbene synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN111116466B reveals a low-cost ZnI2 catalyzed route for high-purity quinoline derivatives. Reduces catalyst cost by 3 orders of magnitude versus Rhodium.
Patent CN113831357A discloses a Lewis acid-catalyzed Michael addition for imidazothiazoles, offering mild conditions and high functional group tolerance for pharmaceutical manufacturing.
Discover advanced synthesis for imidazo[1,2-a]pyridine intermediates via Lewis acid catalysis. Enhance supply chain reliability and reduce manufacturing costs with scalable protocols.
Patent CN112608359B reveals a continuous tubular process for steroid intermediates, offering superior yield and cost reduction in pharmaceutical manufacturing.
Novel synthesis of Netupitant intermediate avoiding Pd catalysts. High yield, mild conditions, scalable for pharma supply chains.
Patent CN115850144A reveals a streamlined Ezetimibe preparation method, offering significant yield improvements and cost reduction in API manufacturing for global supply chains.
Patent CN114790179B reveals a novel route for sulfur-containing 2,4,5-trisubstituted oxazoles. Achieve high purity and cost reduction in fine chemical manufacturing with scalable methods.